Skip to content

PTSD: all studies

Page 30 of 210: studies 291 to 300 of 2,096, newest first. Back to the PTSD overview

Research

MDMA-Assisted Therapy for PTSD Shows Promise for Patients of Diverse Backgrounds

Psychiatric News September 22, 2023

Back to table of contents Previous article Next article Clinical & ResearchFull AccessMDMA-Assisted Therapy for PTSD Shows Promise for Patients of Diverse BackgroundsSearch for more papers by this authorPublished Online:22 Sep 2023https://doi.org/10.1176/appi.pn.2023.10.10.60AbstractMDMA appears to enhance the ability of individuals with PTSD to benefit from psychotherapy by softening their...

From the party to the therapy – MDMA as an alternative for the existing methods of Post-traumatic Stress Disorder treatment

Current Problems of Psychiatry September 22, 2023 Wiktoria Bojarska, Karolina Bury, Radosław Januszczak et al.

Introduction: Post-traumatic Stress Disorder (PTSD) is a mental illness caused by exposure to a traumatic event. The current treatment includes trauma-focused psychotherapy along with selective serotonin reuptake inhibitors (SSRI). It is estimated that for about 40-60% of patients it does not bring the desired improvement, which prompted scientists to look for new methods of pharmacotherapy....

Dealing with invisible scars of war: PTSD in Veterans

Scholarly review . September 15, 2023 Alexandra Dimitrova

The long-term effects of war are extremely present in modern society. However, mental injuries such as posttraumatic stress disorder are commonly overlooked, as they are more obscure than physical wounds and casualties. Today, PTSD continues to affect veterans, and many treatments that have been developed so far are still lacking in effectiveness or have not been thoroughly tested. Prevention...

A small clinical trial of vaporized cannabis for PTSD: suggestive results and directions for future study.

Trials September 9, 2023 Zach Walsh, Ian Mitchell, Kim Crosby et al.

The last few decades have seen increasing interest in the use of cannabis for post-traumatic stress disorder (PTSD). Recent attempts to evaluate the clinical efficacy of cannabis for PTSD were inconclusive and generalizability was limited by undesirable features of the study drug. The present clinical trial evaluated the effects of a commercially available chemovar that was delivered by...

The impact of mindfulness training on posttraumatic stress disorder symptoms, subjective sleep quality, and objective sleep outcomes in police officers.

Psychological Trauma: Theory, Research, Practice and Policy August 31, 2023 Theodore P Imhoff-Smith, Daniel W Grupe

Objective: Sleep disturbances cooccur with posttraumatic stress disorder (PTSD) and are often correlated with PTSD severity. Previous research has shown that sleep problems mediate the relationship between PTSD and negative physical and mental health outcomes but has relied on self-reported sleep quality. We tested the effects of mindfulness training-previously shown to improve sleep quality...

DOI: 10.1037/tra0001566 (opens in new tab) Full text (opens in new tab) Mindfulness Humans Stress disorders, post-traumatic Police +5

use of 3,4-Methylenedioxymethamphetamine (MDMA) in the treatment of Post-Traumatic Stress Disorder (PTSD) - review

Journal of Education, Health and Sport August 15, 2023 Karol Womperski, Rafał Bogacz, Magdalena Gaik et al. 1 citation

Introduction: Post-traumatic stress disorder (PTSD) is a common health issue of complex etiology significantly deteriorating functioning in everyday life. It may develop as a result of exposure to traumatic events like traffic accidents, war experience, sexual abuse and domestic violence. Current methods of treatment consist of trauma-oriented psychotherapy supported by selective serotonin...

Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy

Psychiatric News August 15, 2023 Nick Zagorski 3 citations

The country is the first to make psilocybin and MDMA available for medical use by prescription as part of a psychedelic-assisted psychotherapy regimen. In a move that excited some and concerned others, Australia’s Therapeutic Goods Administration (TGA) earlier this year approved the use of MDMA and psilocybin as adjuncts in the treatment of posttraumatic stress disorder (PTSD) and...

DOI: 10.1176/appi.pn.2023.09.9.20 (opens in new tab) Depression economics Psychotherapist Clinical psychology

The Effectiveness of Mindfulness Based Cognitive Behavioural Therapy (MBCBT) in the treatment of PTSD among couples at PCEA Churches, Nairobi, Kenya

Zenodo (CERN European Organization for Nuclear Research) July 21, 2023 Sheila Wachira, Lilian Wahome, Roseline Olumbe preprint

This study aimed at establishing the efficacy of Mindfulness Based Cognitive Behavioural Therapy (MBCBT) in treating PTSD symptoms among 50 paired couples (50 husbands and 50 wives) in selected PCEA churches in Nairobi County, Kenya. The couples were assigned to either an experimental group or a control group. Those in experimental group were exposed to an MBCBT intervention for a period of 10...

Management of post-traumatic stress disorder symptoms by yoga: an overview.

BMC Complementary Medicine and Therapies July 21, 2023 Nina Laplaud, Anaïck Perrochon, Matthieu Gallou-Guyot et al. 16 citations

Posttraumatic stress disorder (PTSD) can occur after trauma. While PTSD management strategies include first-line pharmacotherapy and psychotherapy, mind-body therapies, such as yoga, are applied in the PTSD population. This overview aimed to summarize the effectiveness of yoga interventions on PTSD symptoms in adults in a systematic review (SR) including randomized controlled trials (RCTs). We...